<DOC>
	<DOCNO>NCT00735501</DOCNO>
	<brief_summary>This observational study conduct Europe . The study aim observe incidence serious adverse drug reaction subject type 2 diabetes Levemir® treatment .</brief_summary>
	<brief_title>Observational Study Observe Safety Levemir® Treatment Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Any patient type 2 diabetes Currently treat basal human insulin therapy ( basal combination oral glucose lower drug insulin ) Selection patient discretion treat physician decision prescribe one study product patient Known suspect allergy study product ( ) relate product . Pregnancy breastfeed intention become pregnant within next 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>